Collectively, our results indicated that RASSF1 acts to restrict EMT and
invasion by indirectly controlling YAP nuclear shuttling and activation through a RhoB -
regulated cytoskeletal remodeling process, with potential implications to delay the progression of RASSF1 - hypermethylated lung
tumors.